The Southern Society for Clinical Investigation logo for print

6359 Tribute Lane
Dora, AL 35062


Phone: 205-648-8429
Cell: 205-566-6090

Contact Us
shadow

Jawahar L. Mehta, MD

Jawahar L. Mehta, MD

University of Arkansas for Medical Sciences
Division of Cardiovascular Diseases

4301 West Markham Street, #832
Little Rock, AR 72205

Phone: 501-296-1426
mehtajl@uams.edu

Assistant: Cheryl Jackson
Phone: (501) 296-1401
CJackson2@uams.edu

Member Since: 1979


Title

Clinical non-invasive cardiologist

Specialty/Subspecialty

Cardiology

Clinical Interest(s)

CCU and outpatient setting

Research Interest(s)

  • oxidant stress
  • inflammation
  • signaling

Current / Former SSCI Roles

speaker on multiple occasions. chair and moderated multiple sessions

Publications

https://www.ncbi.nlm.nih.gov/pubmed/?term=mehta-jl

About Jawahar L. Mehta, MD

Prof. Mehta received his MD degree in India and PhD in Sweden, and completed his post-graduate education in New York and Minnesota. He joined the faculty of the college of medicine of the University of Florida where he rose to be University Research Foundation professor He moved to Little Rock in 2000 as the first Stebbins Chair in Cardiology and Professor of Medicine and Physiology and Biophysics. He led the Division of Cardiovascular Medicine at the University of Arkansas for Medical Sciences and the affiliated Central Arkansas Veterans Affairs Medical Center. He is currently Distinguished Professor of Medicine at the UAMS. Prof Mehta is known for his work on platelet biology and thrombosis in myocardial ischemia in late 1970s and early 1980s. This seminal work led to the trials of anti-platelet drugs in cardiac patients. Prof. Mehta’s research on the biology of LOX-1, a receptor for oxidized low density lipoprotein, over the last 15 years has opened a new target for cardiovascular therapy. His recent work has led to development of small molecules targeting LOX-1, and development of biologics by major pharmaceutical companies. Prof. Mehta serves or has served on the editorial boards of several major cardiology, physiology and pharmacology journals, including Circulation, Hypertension, American Journal of Cardiology, European Heart Journal, Journal of the American College of Cardiology, and the World Journal of Cardiology. He has published over 1200 papers, abstracts and book chapters. He is a member of many prestigious academic societies, including the Association of American Physicians, American Society for Clinical Investigation and Association of University Cardiologists. Grateful patients have established a Mehta Chair in Cardiovascular Research at UAMS in his honor. Recently, Jay and Paulette Mehta Lectureship in Internal Medicine was established in their honor. He has received major national and international awards. Recent major awards include, the Pericle d'Oro International Prize University, Magna Graecia of Catanzaro, Italy; and the UAMS Dean’s Distinguished Faculty Scholar Award in October 2015. He is listed in Marquis Who's Who in America, Who's Who in the World, Who's Who Medicine and Healthcare, and Leading Physicians of the World. As a testament to his clinical skills, Prof. Mehta was named in November 2017 among the top 27 cardiologists in the United States by Forbes magazine. In December 2015, he was invited to the Nobel award ceremonies in Stockholm, Sweden as a special guest. Prof. Mehta has lectured in over 30 countries. He is an honorary professor in the University of Rome, an adjunct Professor in the Clinton School of Public School in Little Rock, AR, and serves as consultant to the University of Arkansas in nanotechnology and biomedical engineering. Many of his trainees occupy positions of prominence in many countries, including China, India, Italy and Japan. His biggest assets- his wife Paulette is a Professor of Hematology/Oncology at UAMS, his daughter Asha Mehta, a senior VP at Acadian Investments and his son Jason (Harvard JD), a former Assistant US attorney, is a partner with Bradley LLP, Tampa, FL.

ruler

The SSCI Thanks Its Sponsors

  • Elsevier sponsors The Southern Society for Clinical Investigation
  •  
  • AstraZeneca sponsors The Southern Society for Clinical Investigation